Works matching IS 00207136 AND DT 2005 AND VI 113 AND IP 2


Results: 26
    1
    2
    3
    4
    5
    6
    7
    8

    Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.

    Published in:
    International Journal of Cancer, 2005, v. 113, n. 2, p. 259, doi. 10.1002/ijc.20569
    By:
    • Smith, Caroline L.;
    • Dunbar, P. Rod;
    • Mirza, Fareed;
    • Palmowski, Michael J.;
    • Shepherd, Dawn;
    • Gilbert, Sarah C.;
    • Coulie, Pierre;
    • Schneider, Joerg;
    • Hoffman, Eric;
    • Hawkins, Robert;
    • Harris, Adrian L.;
    • Cerundolo, Vincenzo
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Inhibition of Ras oncogenic activity by Ras protooncogenes.

    Published in:
    International Journal of Cancer, 2005, v. 113, n. 2, p. 241, doi. 10.1002/ijc.20563
    By:
    • Diaz, Roberto;
    • Lue, Jeffrey;
    • Mathews, Jeremy;
    • Yoon, Andrew;
    • Ahn, Daniel;
    • Garcia-España, Antonio;
    • Leonardi, Peter;
    • Vargas, Marcelo P.;
    • Pellicer, Angel
    Publication type:
    Article
    18
    19

    Mutations of BRAF and RAS are rare events in germ cell tumours.

    Published in:
    International Journal of Cancer, 2005, v. 113, n. 2, p. 329, doi. 10.1002/ijc.20567
    By:
    • Sommerer, Florian;
    • Hengge, Ulrich R.;
    • Markwarth, Annett;
    • Vomschloss, Susanne;
    • Stolzenburg, Jens-Uwe;
    • Wittekind, Christian;
    • Tannapfel, Andrea
    Publication type:
    Article
    20

    Spotlight.

    Published in:
    International Journal of Cancer, 2005, v. 113, n. 2, p. fvii, doi. 10.1002/ijc.20661
    By:
    • O., M.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26